Bausch + Lomb Corp faces a challenging week, with stock performance reflecting broader market trends and sector-specific news.
Bausch + Lomb Corp (BLCO.TO) experienced a decline of 3.12% in its stock price on Monday, closing at C$22.42. Over the past week, the stock is down 0.87%, although it has seen a positive performance over the last month, gaining 7.69%. The health care sector has faced pressure recently, contributing to the stock's current trajectory.
Investor takeaway: Investors should consider the recent performance and broader market conditions while evaluating Bausch + Lomb's stock. The company's recent product launches and market reports may provide some insight into its future potential, but the current bearish outlook from analysts could signal caution.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Bausch + Lomb Corp
BLCO.TO
BLCO.TO
Bausch + Lomb Corp
WealthAwesomeMarket cap
$8.09B
52W high
$25.70
52W low
$18.24
1W change
-3.75%
Beta
0.56
Analyst Price Targets
Based on analyst covering BLCO
Wall Street analysts forecast BLCO stock price to fall 15.0% over the next 12 months.
Consensus
Moderately BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$18.79
-15.0% Upside
Current Price
C$22.10
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BLCO's historical volatility
30-Day Vol
34.4%
Annualized
90-Day Vol
30.7%
Annualized
Trend (90d)
+11.0%
Annualized drift
90d Mean
C$22.98
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$22.39 | C$19.88 – C$25.22 |
| 60 trading days | C$22.69 | C$19.18 – C$26.84 |
| 90 trading days | C$22.98 | C$18.71 – C$28.24 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Bausch + Lomb's stock closed at C$22.42, down 3.12% on Monday.
The stock has a 52-week range between C$18.24 and C$25.70, indicating it is currently trading at 56% of this range, suggesting potential volatility.
Bull case
Bausch + Lomb's recent launch of the EyeGility™ Inserter Preloaded IOL Delivery System represents a notable step forward in ophthalmic technology. This innovation could enhance its market presence and revenue in the specialty eye care sector.
Bear case
The stock is currently under pressure due to a bearish outlook from analysts, with an average price target indicating significant downside potential. Additionally, reports suggest the company might be trading well below its fair value, raising concerns about its financial health.
Recent Price Action
Bausch + Lomb Corp's stock closed at C$22.42 on Monday, reflecting a 3.12% decrease for the day. Over the past week, the stock has seen a slight decline of 0.87%, while its one-month performance shows a gain of 7.69%. Year-to-date, the stock has experienced a marginal decrease of 0.44%. The recent price movements may be attributed to broader market trends affecting the health care sector.
Catalysts and Company News
Recent news surrounding Bausch + Lomb includes the launch of the EyeGility™ Inserter Preloaded IOL Delivery System in the United States, which could enhance its product offerings in the ophthalmology market. Additionally, a report on the ophthalmology devices market has highlighted Bausch + Lomb's position among key competitors, indicating ongoing developments in the sector. However, news suggesting that the stock may be trading 57% below fair value has raised concerns among investors.
Technical Picture
Bausch + Lomb's stock is currently trading above its 50-day moving average of C$22.14 by 1.3%, but slightly below its 200-day moving average of C$22.51 by 0.4%. The stock has a beta of 0.56, indicating lower volatility compared to the market. With a 52-week trading range of C$18.24 to C$25.70, the stock is currently positioned at 56% of its range. The latest trading volume was 900 shares, which is below the 20-day average volume of 2,498 shares, indicating reduced trading activity.
Advertisement
